Lonsurf यूरोपीय संघ - स्पेनी - EMA (European Medicines Agency)

lonsurf

les laboratoires servier - trifluridine, tipiracil clorhidrato de - neoplasias colorrectales - agentes antineoplásicos - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

TIPIRACILO CLORHIDRATO/TRIFLURIDINA 20/8,19 COMPRIMIDOS RECUBIERTOS चिली - स्पेनी - ISPC (Instituto de Salud Pública de Chile)

tipiracilo clorhidrato/trifluridina 20/8,19 comprimidos recubiertos

laboratorios elea chile s.p.a. - tipiracilo clorhidrato;trifluridina - tipiracilo clorhidrato 9,42 mg núcleo; trifluridina 20 mg núcleo - en el tratamiento de pacientes adultos con cáncer colorrectal metastásicoque hayan recibido tratamientos previos o que no sean considerados aptos para el tratamiento con terapias disponibles incluyendo quimioterapia basada en fluoropirimidinas, oxalaplatino e irinotecan, agentes anti-receptor egf y anti-vegf.